Chemo-reirradiation in persistent/recurrent head and neck cancers

Japanese Journal of Clinical Oncology

Volumn 34, Issue 2, 2004, Pages 61-68

  Nagar, Yoodhvir Singh ^a,b   Singh, Shalini ^a   Datta, Niloy Ranjan ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE

Author keywords

Chemoradiotherapy; Recurrent head and neck cancer; Reirradiation

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUCOSA INFLAMMATION; MUCOSAL DISEASE; NEUTROPENIA; PATIENT SELECTION; RADIATION DOSE; RADIATION RESPONSE; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEPTICEMIA; SKIN FIBROSIS; SKIN MANIFESTATION; SKIN TOXICITY; SURVIVAL RATE; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE;

EID: 2342503318     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh017     Document Type: Article

References (29)

1. Vokes EE, Weichselbaun RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Marcial VA, Pajak TF, Kramer S, Davis LW, Stetz J, Laramore GE, et al. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer. Semin Oncol 1988;15:39-60.
3. Stell PM. Survival times in end-stage head and neck cancer. Eur J Surg Oncol 1989;15:407-10.
4. Hong WK, Bromer R. Chemotherapy in head and neck cancer: Current concepts. N Engl J Med 1983;308:75-9.
5. Haraf DJ, Wiechselbaum RR. Treatment selection in T1 and T2 vocal cord carcinoma. Oncology 1988;2:41-7.
6. Haraf DJ, Wiechselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 1996;7:913-8.
7. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324: 1685-90.
8. Schaefer U, Micke O, Schueller P, Willich N. Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy - results of a prospective study. Radiology 2000;216:371-6.
9. Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Current status and future directions. Semin Oncol 2000;27 Suppl 8:25-33.
10. De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, et al. Full dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-62.
11. Stevens KR Jr, Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994;29: 687-98.
12. Pryzant RM, Wendt CD, Delclos L, Peters J. Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 1992;22:941-7.
13. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma - treatment techniques and results. Int J Radiat Oncol Biol Phys 1987;13:953-6.
14. Langlois D, Hoffstetter S, Malissard L, Pernot M, Taghian A. Salvage irradiation of oropharynx and mobile tongue about 192 Iridium brachytherapy in Center Alexis Vautrin. Int J Radiat Oncol Biol Phys 1988; 14:849-53.
15. Mazeron JJ, Langlois D, Glaubiger D, Huart J, Martin M, Raynal M, et al. Salvage irradiation of oropharyngeal cancers using Iridium 192 wire implants: 5 year results of 70 cases. Int J Radiat Oncol Biol Phys 1987;13: 957-62.
16. Puthawala AA, Syed AM, Gates TC. Irdium-192 implants in the treatment of tonsillar region malignancies. Arch Otolaryngol 1985;111:812-5.
17. Eisbruch A, Dawson L. Re-irradiation of head and neck tumors: Benefits and toxicities. Haemat Oncol Clin N Am 1999;13:825-36.
18. Levendag PC, Meeuwis CA, Visser AG. Reirradiation of recurrent head and neck cancers: External and/or interstitial radiation therapy. Radiother Oncol 1992;23:6-15.
19. Fontanesi J, Hetzler D, Ross J. Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192. Int J Radiat Oncol Biol Phys 1989;17:365-9.
20. Pomp J, Levendag P. van Putten W. Reirradiation of recurrent tumour in the head and neck. Am J Clin Oncol 1988;11:543-9.
21. Gandia D, Wibault P, Guillot T, Bensmaine A, Armand JP, Marandas P, et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 1993;15:8-15.
22. Weppelmann B, Wheeler RH, Peters GE, Kim RY, Spencer SA, Meredith RF, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 1992;22: 1051-6.
23. Emami B, Bignardi M, Spector GJ, Devineni VR, Hederman MA. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987;97:85-8.
24. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, et al. RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:1299-304.
25. Skolyzewski J, Korzeniowski S, Reinfuss M. The reirradiation of recurrences of head and neck cancer. Br J Radiol 1980;53:462-5.
26. Hartsell WF, Thomas CR Jr, Murthy AK, Taylor SG IV, Haselow RE. Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer. Am J Clin Oncol 1994;17:338-43.
27. Wang CC, McIntyre J. Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 1992;26:783-5.
28. Dawson LA, Myers LL, Bradford CR, Chepeha DB, Hogikyan ND, Teknos TN, et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:377-85.
29. Stell PM. Time to recurrence of squamous cell carcinoma of head and neck. Head Neck 1991;13:277-81.